Events & Ideas

Our Work

Prescription Medicines

MAPS Psychedelic Science 2023

June 19-23, 2023 | Denver, CO Jack Henningfield and Ryan Lanier will be attending. VIEW CONFERENCE

Prescription Medicines

Abuse Potential Similarities Between Hypnotic Classes: Real-World Data

Moline ML, Cheng JY, Durgin C, Pype S, Buchhalter A, Henningfield J To identify differences and similarities in real-world abuse potential between dual orexin receptor antagonists (DORAs) and other drugs used as hypnotics, either Schedule IV (CIV) or unscheduled. DORAs, the newest hypnotic class, were placed in CIV based largely on human abuse potential (HAP)… Read More

Prescription Medicines

CPDD 85th Annual Scientific Meeting

June 17-21, 2023 | Denver, CO Judy Ashworth, Jack Henningfield, August Buchhalter, Ryan Lanier and Caitlyn Durgin will be attending. VIEW CONFERENCE WEBSITE Posters: Within-Subject Variations in Opioid Sensitivity Across Patient-reported Outcomes, Observer-Ratings, Physiological Endpoints, and Analgesic Responses A Novel 3 mg Naloxone Nasal Spray for the Over-the-Counter Market Abuse Potential Similarities Between Hypnotic Classes:… Read More

OTC Products

A Novel 3 mg Naloxone Nasal Spray for the Over-the-Counter Market

Ashworth J, Davis VG, Mannion R, Hufford M To be presented at the 85th CPDD Annual Scientific Meeting, Poster Session 2, June 19, 2023.

Prescription Medicines

Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin across Diverse Indications

Lanier R, Schindler E, Kelmendi B, Bogenschutz M, Durgin C, Ashworth J Psilocybin and other psychedelics are currently being investigated for their potential to treat or assist in the treatment of a range of neurological and psychiatric conditions, including substance use disorders. These conditions have overlapping, but distinct pathophysiologies and treatment modalities. How, then, is… Read More

Prescription Medicines

Abuse Potential Differs Between Hypnotic Classes: Real-World Data

Moline ML, Cheng JY, Durgin C, Pype S, Buchhalter A, Henningfield J The two major hypnotic classes with distinct mechanisms of action, GABAergic drugs (benzodiazepines [BZs] and nonbenzodiazepines [i.e. zolpidem]) and dual orexin receptor antagonists (DORAs), are Schedule IV (CIV) drugs, but have notable differences in human abuse profiles. BZs are associated with drug tolerance/dependence,… Read More

Cure Addiction Now Forum & Webinar

March 11, 2023 | Los Angeles, CA (and Virtual) Judy Ashworth will be attending in person as a panelist for the discussion. VIEW CONFERENCE WEBSITE

OTC Products, Dietary Ingredients & Supplements

2023 CHPA Annual Self-Care Leadership Summit

March 19-21, 2023 | Orlando, FL Lucy Owen will be attending VIEW CONFERENCE WEBSITE